About
Laura A. Brege has served as an ACADIA director since May 2008. She has been a Senior Advisor to BridgeBio Pharma since 2017 and previously was Managing Director of Cervantes Life Science Partners, President and CEO of Nodality, and Executive Vice President and Chief Operating Officer of Onyx Pharmaceuticals. She currently serves on the boards of Edgewise Therapeutics, Mirum Pharmaceuticals, Pacira BioSciences and T-knife Therapeutics. She earned her undergraduate degree from Ohio University and an M.B.A. from the University of Chicago.
Roles
Acadia Pharmaceuticals Inc.
Director · Current role
May 2008–present
BridgeBio Pharma, Inc.
Senior Advisor
2017 - present
Cervantes Life Science Partners, LLC
Managing Director
2015 - 2017
Nodality, Inc.
President and Chief Executive Officer
2012 - 2015
Onyx Pharmaceuticals, Inc.
Executive Vice President and Chief Operating Officer
2006 - 2012
External Roles
Edgewise Therapeutics, Inc.
Director
—
Mirum Pharmaceuticals, Inc.
Director
—
Pacira BioSciences, Inc.
Director
—
T-knife Therapeutics, Inc.
Director
—
Director Compensation
FY 2025
Fees earned or paid in cash
$38,116
Also at Acadia Pharmaceuticals Inc.